Top Buy
| Wertpapier | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 54 | 0 | 6 | 0 | 830,10 € | 800,00 € | -3,63 % |
| Biogen Inc. | 50 | 1 | 4 | 0 | 208,30 € | 293,22 € | 40,77 % |
| Boston Scientific | 50 | 0 | 4 | 0 | 71,50 € | 73,88 € | 3,33 % |
| Vertex Pharmaceuticals Inc. | 49 | 2 | 5 | 0 | 435,05 € | 428,60 € | -1,48 % |
| Regeneron Pharmaceuticals Inc. | 39 | 1 | 3 | 0 | 967,20 € | 1.006,8 € | 4,09 % |
| UnitedHealth Group Inc. | 36 | 1 | 6 | 0 | 447,90 € | 543,04 € | 21,24 % |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | 143,30 € | 236,30 € | 64,90 % |
| Intuitive Surgical Inc | 34 | 0 | 0 | 0 | 405,20 € | 394,95 € | -2,53 % |
| Johnson & Johnson | 34 | 1 | 3 | 0 | 135,66 € | 187,15 € | 37,96 % |
| Cytokinetics Inc. | 33 | 1 | 7 | 0 | 48,40 € | 83,56 € | 72,65 % |
| Neurocrine Bioscience | 32 | 0 | 3 | 0 | 121,90 € | 140,87 € | 15,56 % |
| Merck & Co. Inc. | 31 | 1 | 3 | 0 | 119,20 € | 124,97 € | 4,84 % |
| Insmed Inc. | 30 | 1 | 12 | 1 | 59,50 € | 63,62 € | 6,93 % |
| Pfizer Inc. | 28 | 4 | 1 | 0 | 25,54 € | 41,10 € | 60,94 % |